Cargando…

Cancer care coordinators in stage III colon cancer: a cost-utility analysis

BACKGROUND: There is momentum internationally to improve coordination of complex care pathways. Robust evaluations of such interventions are scarce. This paper evaluates the cost-utility of cancer care coordinators for stage III colon cancer patients, who generally require surgery followed by chemot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blakely, Tony, Collinson, Lucie, Kvizhinadze, Giorgi, Nair, Nisha, Foster, Rachel, Dennett, Elizabeth, Sarfati, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523949/ https://www.ncbi.nlm.nih.gov/pubmed/26238996 http://dx.doi.org/10.1186/s12913-015-0970-5

Ejemplares similares

Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer by Age and Hormone Receptor Status: A Cost-Utility Analysis
por: Leung, William, et al.
Publicado: (2016)

A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity
por: Teng, Andrea M., et al.
Publicado: (2017)

Home modification to reduce falls at a health district level: Modeling health gain, health inequalities and health costs
por: Wilson, Nick, et al.
Publicado: (2017)

How much might a society spend on life-saving interventions at different ages while remaining cost-effective? A case study in a country with detailed data
por: Kvizhinadze, Giorgi, et al.
Publicado: (2015)

Health Benefits and Cost-Effectiveness From Promoting Smartphone Apps for Weight Loss: Multistate Life Table Modeling
por: Cleghorn, Christine, et al.
Publicado: (2019)

The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study
por: Sarfati, Diana, et al.
Publicado: (2009)

Patterns of Cancer Care Costs in a Country With Detailed Individual Data
por: Blakely, Tony, et al.
Publicado: (2015)

Why equal treatment is not always equitable: the impact of existing ethnic health inequalities in cost-effectiveness modeling
por: McLeod, Melissa, et al.
Publicado: (2014)

Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program
por: Pearson, Amber L, et al.
Publicado: (2014)

Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand
por: Blakely, Tony, et al.
Publicado: (2019)

Ethnic and socioeconomic trends in breast cancer incidence in New Zealand
por: Cunningham, Ruth, et al.
Publicado: (2010)

Health, Health Inequality, and Cost Impacts of Annual Increases in Tobacco Tax: Multistate Life Table Modeling in New Zealand
por: Blakely, Tony, et al.
Publicado: (2015)

Correction: Health, Health Inequality, and Cost Impacts of Annual Increases in Tobacco Tax: Multistate Life Table Modeling in New Zealand
por: Blakely, Tony, et al.
Publicado: (2016)

Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis
por: McLeod, Melissa, et al.
Publicado: (2020)

Ethnic inequalities in cancer incidence and mortality: census-linked cohort studies with 87 million years of person-time follow-up
por: Teng, Andrea M., et al.
Publicado: (2016)

Home‐based chemotherapy for stage III colon cancer patients in Thailand: Cost‐utility and budget impact analyses
por: Kulthanachairojana, Nattanichcha, et al.
Publicado: (2020)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
por: Eggington, S, et al.
Publicado: (2006)

Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer
por: Sinicrope, Frank A, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers
por: Soni, Amy, et al.
Publicado: (2015)

Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals
por: Pumpalova, Yoanna, et al.
Publicado: (2021)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Gold (III) Derivatives in Colon Cancer Treatment
por: Gurba, Agata, et al.
Publicado: (2022)

Patterns of age disparities in colon and lung cancer survival: a systematic narrative literature review
por: Pilleron, Sophie, et al.
Publicado: (2021)

The impact of patient comorbidity on cancer stage at diagnosis
por: Gurney, Jason, et al.
Publicado: (2015)

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
por: Tan, Sarah Xinhui, et al.
Publicado: (2023)

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer
por: Sinicrope, Frank A, et al.
Publicado: (2020)

A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes
por: Sarfati, Diana, et al.
Publicado: (2014)

Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study
por: Shibahara, Hidetoshi, et al.
Publicado: (2022)

Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk
por: Nghiem, Nhung, et al.
Publicado: (2019)

531 Utilization of a Nurse Care Coordinator to Streamline the Outpatient Experience
por: Neal, Joya, et al.
Publicado: (2023)

Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer
por: Austin, Jessica D., et al.
Publicado: (2023)

Protecting an island nation from extreme pandemic threats: Proof-of-concept around border closure as an intervention
por: Boyd, Matt, et al.
Publicado: (2017)

Significance of the Lymph Node Ratio in Stage III Colon Cancer
por: Telian, Simon H., et al.
Publicado: (2008)

Comparing health gains, costs and cost-effectiveness of 100s of interventions in Australia and New Zealand: an online interactive league table
por: Carvalho, Natalie, et al.
Publicado: (2022)

Utilization and cost sharing for preventive cancer screenings
por: Jennings, Nicholas, et al.
Publicado: (2021)

Taxes and Subsidies for Improving Diet and Population Health in Australia: A Cost-Effectiveness Modelling Study
por: Cobiac, Linda J., et al.
Publicado: (2017)

Postoperative mortality in New Zealand following general anaesthetic: demographic patterns and temporal trends
por: Gurney, Jason K, et al.
Publicado: (2020)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1ri8it39ivv4km0om91t1qud4t